Patent · US Active

Antibodies to VLA-1

US7723073B2 · kind B2 · utility

7Cited by
23References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 16, 2008
Grant dateMay 25, 2010
Priority date
Expiry dateJan 16, 2028

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A90/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Antibodies that specifically bind to VLA-1 integrin and methods of using these antibodies to treat immunological disorders in a subject. Also included are crystal structures of complexes formed by VLA-1 antibodies and their ligands, and VLA-1 antagonists and agonists identified by using the structure coordinates of these structures.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.